Biotech

Latest Articles

Former Seagen CEO reveals new start-up Ottimo Pharma

.After antibody-drug conjugate (ADC) expert Seagen was sold to Pfizer in 2014 for a tremendous $43 b...

Ironwood creates more bid for $1B GI drug with new subgroup information

.On the heels of a stage 3 win that fell short to wow entrepreneurs, Ironwood Pharmaceuticals is bac...

Novartis inks $150M offer for autoimmune molecular glue

.Don't cease Monte Rosa Therapeutics now. The Boston-based biotech is having a ball after authorizin...

Jade carves out officer staff along with Chinook veterinarians-- Chutes &amp Ladders

.Welcome to this week's Chutes &amp Ladders, our roundup of considerable management hirings, shootin...

Septerna goes public with upsized offering of $288M

.Commemorating his provider's upsized going public (IPO), Septerna chief executive officer Jeffrey F...

AbbVie creates Richter richer, paying for $25M to make up invention contract

.AbbVie has actually come back to the resource of its antipsychotic powerhouse Vraylar trying to fin...

GenSight gets into ultimate weeks of money runway as revenue flow edges out of scope

.GenSight Biologics is weeks off of running out of loan. Once again. The biotech simply has sufficie...

AZ licenses disposed of uncommon condition drug to Monopar Therapeutics

.Monopar Therapeutics is bouncing back a medication from the scrap heap of AstraZeneca's unusual dis...

Arcus' brand-new HIF-2a data in kidney cancer mention prospective advantage over Merck's Welireg, professionals claim

.With new records out on Arcus Biosciences' experimental HIF-2a inhibitor, one team of analysts esti...

Roche bets up to $1B to extend Dyno genetics therapy shipping pact

.After forming a genetics treatment alliance with Dyno Rehabs in 2020, Roche is back for even more.I...

Lundbeck slashes worth of $250M Abide acquistion after discomfort misfortune

.Lundbeck is actually slashing guide worth of its $250 million Abide Therapeutics acquistion in feed...

Real- Globe Information Satisfies Clinical Test Design: Enhancing Methods as well as Site Collection

.The integration of real-world records (RWD) right into protocol usefulness and also internet site a...

Where are they today? Catching up with previous Intense 15 honorees

.At this year's Intense Biotech Top in Boston, our company overtook innovators in the biotech sector...

Merck gets preclinical DNA biotech for $1.3 B biobucks

.Merck &amp Co. is setting down $30 thousand beforehand to buy Yale spinout Modifi Biosciences, a ba...

Radiopharma Alpha-9 raises $175M series C to fund professional press

.Alpha-9 Oncology has raised a $175 thousand series C round to stake its own clinical-stage radiopha...

Ocuphire to change right into gene therapy biotech via Opus acquistion

.Eye drug creator Ocuphire Pharma is actually acquiring genetics therapy programmer Opus Genes in an...

Roche culls hack candidate, turns KRAS program in Q3 upgrade

.Roche's chronic cough plan has faltered to a standstill. The drugmaker, which axed the plan after t...

Merck- Gilead long-acting dental combo subdues HIV for 48 weeks

.Gilead Sciences and also Merck &amp Co. have assisted their once-weekly HIV blend treatment past an...

Lykos accepts FDA check out that MDMA authorization relies on fresh test

.Lykos Rehabs might have shed three-quarters of its team following the FDA's rejection of its own MD...

Septerna organizes $158M IPO to finance readouts for GPCR pipeline

.Septerna might be yet to disclose "any sort of meaningful professional records," yet the biotech pl...